BPG is committed to discovery and dissemination of knowledge
Observational Study
Copyright ©The Author(s) 2026.
World J Psychiatry. Feb 19, 2026; 16(2): 111577
Published online Feb 19, 2026. doi: 10.5498/wjp.v16.i2.111577
Table 1 Videoconferencing-delivered exposure and response prevention for obsessive-compulsive disorder
Modules
Description
Diagnostic evaluationICD-10 diagnosis of OCD established by detailed evaluation
Management planPharmacological and psychosocial interventions for treatment
Brief psychoeducation1-2 sessions explaining OCD and its treatment. Agreement on medication and ERP treatment between patients, family members, and therapists
Scale-based evaluationsYBOCS screen for OC symptoms not reported initially. YBOCS rating of the severity of OCD
Functional analysisStructured behavioral analysis following the “ABC” paradigm[44]
Pre-treatment symptom tracking1-2 weeks of daily record of symptoms in structured formats by patients and family members. Exchanged with the clinician using Google sheets or WhatsApp text messages
Hierarchy of symptomsAscending hierarchy of symptoms/situations rated on a 0%-100% scale of subjective distress; jointly constructed by patients, family members, and therapists.
ERP constituentsDetailed psychoeducation, symptom tracking within and between ERP sessions, anxiety management (Benson’s Relaxation Training[45], exposure sessions, post-session processing
Post-session processing includes discussions about patients’ and family members’ experience of ERP, learning about ERP, reality of the patient’s obsessions, neutralizing strategies, and adaptive coping
VC-delivered sessionsAll sessions at home are attended by patients and family members and supervised by therapists. Minimum duration 30 minutes. Average 1 session every 7-14 days. Patients are actively engaged by therapists during sessions to avoid unnecessary interruptions or distractions. Patients are carefully monitored during the sessions for obsessional thoughts, compulsions, or neutralizing acts. Additional advice by phone calls or WhatsApp text messages
Homework assignmentsDaily exposure sessions supervised by the family member who was chosen by the patient as a co-therapist
Hybrid treatmentCombination of VC and in-person sessions. Alternative modes of communication were used to minimize disruptions when the VC connection failed
Preventing relapseRegular VC follow-ups, further education, and booster sessions of ERP if required
SupervisionVC groups for training and regular supervision of therapist carrying out ERP
Table 2 Participants of the videoconferencing-delivered and inpatient exposure and response prevention treatment groups
Variables
VC-delivered ERP (from 2020-2023) (n = 20)
Inpatient ERP (from 2016 and 2017) (n = 17)
Comparisons
Age (year), mean ± SD30.90 ± 8.10 (range 18-56)31.71 ± 13.60 (range 16-61)t = 0.22; df = 35; P = 0.82 - not significant
Genderχ2 = 1.30; df = 1; P = 0.25 - not significant
Men127
Women810
Marital statusχ2 = 2.47; df = 1; P = 0.12 - not significant
Single137
Married710
Educationχ2 = 0.29; df = 1; P = 0.59 - not significant
College graduates1007
School education1010
Residenceχ2 = 0.50; df = 1; P = 0.48 - not significant
Urban1410
Rural67
Comorbidityχ2 = 1.96; df = 1; P = 0.16 - not significant1
Depressive disorders 58
Schizophrenia spectrum disorders22
Bipolar disorder30
Other disorders02
Duration of OCD (years), mean ± SD7.43 ± 6.51 (range 1-25)9.00 ± 6.16 years (range 2-26)t = 0.75; df = 35; P = 0.46 - not significant
Table 3 Videoconferencing- delivered exposure and response prevention treatment for obsessive-compulsive disorder: Comparison with inpatient treatment
Variables
VC-based ERP (from 2020-2023) (n = 20)
Inpatient ERP (from 2016 and 2017) (n = 17)
Comparisons
Duration of ERP (month), mean ± SD5.5 ± 3.3 (range 3-9)2.5 ± 2.4 (range 2-5)t = 3.11; df = 35; P < 0.01
Frequency of sessionsClinician supervised: Every 7-14 daysDaily sessions supervised by clinicians and attended by family members-
Family member supervised: Daily
Average number of clinician-supervised ERP sessions, mean ± SD11 ± 5.4 (range 6-18)63.5 ± 30.1 (range 45-90)t = 7.67; df = 35; P < 0.001
Duration of ERP sessions30-45 minutes40-75 minutes-
Average pre-treatment YBOCS scores, mean ± SD27.45 ± 5.65 (range 17-38)28.07 ± 7.84 (range 11-38)t = 0.44; df = 35; P = 0.67 - not significant
Average post-treatment YBOCS scores, mean ± SD4.02 ± 3.85 (range 0-13)9.73 ± 8.11 (range 0-24)t = 2.80; df = 35; P < 0.05
Pre-treatment vs post-treatment YBOCS scoresSignificant change (P < 0.001)Significant change (P < 0.001)t = 2.0; df = 35; P = 0.05 - not significant
Change in YBOCS scores, mean ± SD22.43 ± 7.7917.36 ± 7.49
Cohen’s d values4.852.30-
Duration of follow-up6-26 months--
Outcome at last follow-up YBOCS and remission criteria1YBOCS score at last follow-up: 3.55 ± 2.35--
All patients had remained in recovery and none had relapsed